Salix Pharmaceuticals
VC Fund
Raleigh, United States
Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders. For more than 20 years, they have licensed, developed, and marketed innovative products to treat GI problems. It's their mission to give healthcare providers and patients the most effective solutions ingastroenterology.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Salix Pharmaceuticals invests in
Stages Salix Pharmaceuticals invests in
Countries Salix Pharmaceuticals invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Derbyshire
|
|||
|
Carolyn Logan
|
|||
|
Ellen McKim
|
|||
Howard Franklin
|
|||
|
Nicola Kayel
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Adam Derbyshire
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Carolyn Logan
CEO
|
CEO | Total investments: 0 | Find email | |
|
Ellen McKim
SVP, Marketing
|
SVP, Marketing | Total investments: 0 | Find email | |
|
Howard Franklin
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
|
Nicola Kayel
Vice President & GI Marketing
|
Vice President & GI Marketing | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Atlantic Healthcare
|
Atlantic Healthcare plc is a specialist pharmaceutical company, focused on developing and commercializing therapeutics that address unmet patient needs and rare diseases. Our work currently focuses on the gastrointestinal (GI) tract and targets the treatment of GI diseases, which have a debilitating effect on the lives of millions of people.Weown the exclusive worldwide rights to alicaforsen, a pipeline within a drug, with the potential to establish a new class of treatments for Inflammatory Bowel Disease (IBD) and other GI diseases.We also own the worldwide rights to renzapride, a molecule with a unique dual mode of action and the potential to treat a variety of GI motility disorders. | $24M / Series B / Nov 01, 2016 | |
|
Atlantic Healthcare
|
Atlantic Healthcare plc is a specialist pharmaceutical company, focused on developing and commercializing therapeutics that address unmet patient needs and rare diseases. Our work currently focuses on the gastrointestinal (GI) tract and targets the treatment of GI diseases, which have a debilitating effect on the lives of millions of people.Weown the exclusive worldwide rights to alicaforsen, a pipeline within a drug, with the potential to establish a new class of treatments for Inflammatory Bowel Disease (IBD) and other GI diseases.We also own the worldwide rights to renzapride, a molecule with a unique dual mode of action and the potential to treat a variety of GI motility disorders. | $23.1M / Series A / Jan 01, 2013 |
Co-Investors
Fullbrook Thorpe Investments
2 deals together
LDC
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Salix Pharmaceuticals invest in?
Salix Pharmaceuticals invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Salix Pharmaceuticals?
Public channels for Salix Pharmaceuticals include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Salix Pharmaceuticals?
The team at Salix Pharmaceuticals includes Adam Derbyshire (Chief Financial Officer), Carolyn Logan (CEO) and Ellen McKim (SVP, Marketing), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
